Arbutus Biopharma Market Sentiment

Arbutus Biopharma Corp

ABUSNASDAQ

$5.12

0.071.39%

Last update: Sep 17, 9:30 AM

Market sentiment signals for Arbutus Biopharma (ABUS): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 14.2% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

4 analysts

Options Flow (P/C)

0.00

More calls — Bullish

417 calls · 0 puts

Avg Consensus PT

+7.4%

Highest Price Target

+36.7%

Jefferies

Lowest Price Target

-2.3%

Chardan Capital

Short Interest

14.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Nov 14, 2025	Chardan Capital	Keay Nakae—	-2.3%	$5 → $5	Maintained	Buy
Aug 11, 2025	Chardan Capital	Keay Nakae—	-2.3%	$5 → $5	Maintained	Buy
Mar 28, 2025	Chardan Capital	Keay Nakae—	-2.3%	$5 → $5	Maintained	Buy
Jan 21, 2025	HC Wainwright & Co.	Ed Arce—	-2.3%	$5 → $5	Maintained	Buy
Nov 20, 2024	Chardan Capital	Keay Nakae—	-2.3%	$5 → $5	Maintained	Buy
Nov 18, 2024	HC Wainwright & Co.	Ed Arce—	-2.3%	$5 → $5	Maintained	Buy
Nov 7, 2024	HC Wainwright & Co.	Ed Arce—	-2.3%	$5 → $5	Maintained	Buy
Nov 6, 2024	Chardan Capital	Keay Nakae—	-12.1%	$4 → $5	Maintained	Buy
Sep 5, 2024	Jefferies	Dennis Ding—	+36.7%	$5 → $7	Maintained	Buy
Aug 2, 2024	JMP Securities	Roy Buchanan—	-2.3%	$4 → $5	Maintained	Market Outperform
Jun 7, 2024	HC Wainwright & Co.	Ed Arce—	-2.3%	$5 → $5	Maintained	Buy
Jun 6, 2024	HC Wainwright & Co.	Ed Arce—	-2.3%	$5 → $5	Maintained	Buy
Jun 5, 2024	Chardan Capital	Keay Nakae—	-21.9%	$4 → $4	Maintained	Buy
May 3, 2024	Chardan Capital	Keay Nakae—	-21.9%	$4 → $4	Maintained	Buy
Apr 4, 2024	JMP Securities	Roy Buchanan—	-21.9%	$4 → $4	Maintained	Market Outperform
Mar 1, 2024	Chardan Capital	Keay Nakae—	-21.9%	$4 → $4	Maintained	Buy
Mar 1, 2024	HC Wainwright & Co.	Ed Arce—	-2.3%	$6 → $5	Maintained	Buy